David Hawkings: New bill aims to loosen FDA’s drug testing rules
The Food and Drug Administration — and in particular its ability to collect crucial fees — is at stake in a new legislative proposal.
The Food and Drug Administration — and in particular its ability to collect crucial fees — is at stake in a new legislative proposal. Sen. Ron Johnson (R-Wis.) wants to give drug companies more leeway to let people try drugs experimentally. For more on this and other congressional doings, Federal Drive with Tom Temin turns to Roll Call Senior Editor David Hawkings.
Copyright © 2024 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.
